🔎 Trials Near Me

Home › Prostate Cancer › New Jersey

Prostate Cancer clinical trials in New Jersey

42 studies for Prostate Cancer are looking for participants at sites in New Jersey.

Cities in New Jersey

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

  • Summit Health, Clifton
Recruiting
Ages 18 and older · Men · Updated Sep 28, 2026 · NCT06496256

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • START New Jersey, East Brunswick
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 28, 2026 · NCT06095089

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06136650

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT03866382

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  • START New Jersey, East Brunswick
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07719361

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • MSK Basking Ridge, Basking Ridge
  • MSK Monmouth, Middletown
  • MSK Bergen, Montvale
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07028853

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

  • John Theurer Cancer Center, Hackensack
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07543055

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Astera Cancer Center, East Brunswick
  • New Jersey Urology LLC, Voorhees Township
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Hackensack
  • Research Site, Voorhees Township
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06952803

Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 3
All ages · Men · Updated Sep 18, 2026 · NCT07548164

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

  • GSK Investigational Site, East Brunswick
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06990880

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016), Hackensack
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737

A Study of Changes to Prostate Procedures

  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Consent Only), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Consent Only), Montvale
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 15, 2026 · NCT06986083

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

  • Summit Health, Saddle Brook
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 15, 2026 · NCT07332000

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

  • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent only), Middletown
  • Memorial Sloan Kettering Bergen (Consent Only), Montvale
Recruiting
All ages · Men · Updated Sep 11, 2026 · NCT00588185

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus, Elizabeth
  • Jersey City Medical Center, Jersey City
  • Saint Barnabas Medical Center, Livingston
  • and 7 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

  • Research Site, East Brunswick
  • Research Site, Hackensack
RecruitingPhase 1/2
Ages 18 to 100 · Men · Updated Sep 9, 2026 · NCT07529717

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Englewood Hospital and Medical Center, Englewood
  • CentraState Medical Center, Freehold
  • Hackettstown Medical Center, Hackettstown
  • and 7 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • AtlantiCare Health Park-Cape May Court House, Cape May Court House
  • AtlantiCare Surgery Center, Egg Harbor
  • and 3 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT07200830

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Jefferson Cherry Hill Hospital, Cherry Hill
  • Memorial Sloan Kettering Monmouth, Middletown
  • and 2 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT06931340

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Hackensack University Medical Center, Hackensack
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06632977

A Study of Tarlatamab for People With Prostate Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 31, 2026 · NCT07111507

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • START New Jersey, East Brunswick
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 24, 2026 · NCT07745361

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Cooper Hospital University Medical Center, Camden
  • Rutgers Cancer Institute of New Jersey, New Brunswick
  • Robert Wood Johnson University Hospital Somerset, Somerville
  • and 2 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211

Radiation Therapy Approaches for People With Prostate Cancer

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
All ages · All sexes · Updated Aug 12, 2026 · NCT07751159

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Recruiting
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06954337

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
RecruitingPhase 2
Ages 18 and older · Men · Updated Jul 30, 2026 · NCT05751434

A Study of a New PET Scanner in People With Cancer

  • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent Only), Middletown
  • Memorial Sloan Kettering Bergen (Consent Only ), Montvale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT07690917

A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide

  • Bayer, Whippany
RecruitingObservational study
Ages 55 and older · Men · Updated Jun 26, 2026 · NCT07672119

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Jun 25, 2026 · NCT06457919

A Study of Lower Dose Radiation Therapy for People With Prostate Cancer

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · Men · Updated Jun 18, 2026 · NCT07635238

Clinical Trial of Approaches to Prostate Cancer Surgery

  • Hackensack Meridian Health, Hackensack
Recruiting
Ages 40 to 80 · Men · Updated Apr 22, 2026 · NCT05155501

A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · Men · Updated Apr 16, 2026 · NCT06347705

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Recruiting
Ages 18 and older · Men · Updated Mar 23, 2026 · NCT07011342

Study of AZD0754 in Participants With Metastatic Prostate Cancer

  • Research Site, Hackensack
RecruitingPhase 1/2
Ages 18 to 130 · Men · Updated Feb 23, 2026 · NCT06267729

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

  • START, Astera, East Brunswick
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07145255

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • Hackensack University Medical Center, Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT06778863

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Brunswick
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Hackensack University Medical Center, Hackensack
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.